NEFL and Parkinson disease: This might explain why our proteomic analysis could not detect common biomarkers like neurofilaments in TF, although NfL has been described in the TF of Parkinson’s disease patients using the ultrasensitive Single Molecule Array (SIMOA) assay [28].